おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sansure Biotech
company
About
Sansure biotech is a manufacturer targeting qPCR diagnostic kits with its innovated technology.
- 5001 - 10000
Highlights
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- $77M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 5001 - 10000
- Operating Status
- Active
Sansure Biotech Inc. is a Changsha, Hunan Province-based biotechnology company focusing on molecular diagnosis and genetic testing techniques. It develops and manufactures nucleic acid extraction kits, real time polymerase chain reaction(PCR) diagnostic & research kits and fluorescence systems.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$77M
Sansure Biotech has raised a total of
$77M
in funding over 2 rounds. Their latest funding was raised on
Jan 2, 2018 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 2, 2018 | Corporate Round | $77M | 2 |
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Sansure Biotech is funded by 2 investors.
Lilly Asia Ventures
and Junhe Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Corporate Round |
|
|
— | Corporate Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
